Copyright Reports & Markets. All rights reserved.

Global and China Cholera Vaccine Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Cholera Vaccine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cholera Vaccine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cholera Vaccine Market Size Growth Rate by Type
    • 1.4.2 Dukoral
    • 1.4.3 Shanchol
    • 1.4.4 Vaxchora
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cholera Vaccine Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Scientific Research
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Cholera Vaccine Market Size, Estimates and Forecasts
    • 2.1.1 Global Cholera Vaccine Revenue 2015-2026
    • 2.1.2 Global Cholera Vaccine Sales 2015-2026
  • 2.2 Global Cholera Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Cholera Vaccine Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Cholera Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Cholera Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Cholera Vaccine Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Cholera Vaccine Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Cholera Vaccine Revenue Forecast by Region (2021-2026)

3 Global Cholera Vaccine Competitor Landscape by Players

  • 3.1 Global Top Cholera Vaccine Sales by Manufacturers
    • 3.1.1 Global Cholera Vaccine Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Cholera Vaccine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Cholera Vaccine Manufacturers by Revenue
    • 3.2.1 Global Cholera Vaccine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cholera Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cholera Vaccine Revenue in 2019
    • 3.2.5 Global Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Cholera Vaccine Price by Manufacturers
  • 3.4 Global Cholera Vaccine Manufacturing Base Distribution, Product Types
    • 3.4.1 Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cholera Vaccine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cholera Vaccine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cholera Vaccine Market Size by Type (2015-2020)
    • 4.1.1 Global Cholera Vaccine Sales by Type (2015-2020)
    • 4.1.2 Global Cholera Vaccine Revenue by Type (2015-2020)
    • 4.1.3 Cholera Vaccine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cholera Vaccine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cholera Vaccine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cholera Vaccine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cholera Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cholera Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Cholera Vaccine Market Size by Application (2015-2020)
    • 5.1.1 Global Cholera Vaccine Sales by Application (2015-2020)
    • 5.1.2 Global Cholera Vaccine Revenue by Application (2015-2020)
    • 5.1.3 Cholera Vaccine Price by Application (2015-2020)
  • 5.2 Cholera Vaccine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cholera Vaccine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cholera Vaccine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cholera Vaccine Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Cholera Vaccine Market Size YoY Growth 2015-2026
    • 6.1.1 China Cholera Vaccine Sales YoY Growth 2015-2026
    • 6.1.2 China Cholera Vaccine Revenue YoY Growth 2015-2026
    • 6.1.3 China Cholera Vaccine Market Share in Global Market 2015-2026
  • 6.2 China Cholera Vaccine Market Size by Players (International and Local Players)
    • 6.2.1 China Top Cholera Vaccine Players by Sales (2015-2020)
    • 6.2.2 China Top Cholera Vaccine Players by Revenue (2015-2020)
  • 6.3 China Cholera Vaccine Historic Market Review by Type (2015-2020)
    • 6.3.1 China Cholera Vaccine Sales Market Share by Type (2015-2020)
    • 6.3.2 China Cholera Vaccine Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Cholera Vaccine Price by Type (2015-2020)
  • 6.4 China Cholera Vaccine Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Cholera Vaccine Sales Forecast by Type (2021-2026)
    • 6.4.2 China Cholera Vaccine Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Cholera Vaccine Price Forecast by Type (2021-2026)
  • 6.5 China Cholera Vaccine Historic Market Review by Application (2015-2020)
    • 6.5.1 China Cholera Vaccine Sales Market Share by Application (2015-2020)
    • 6.5.2 China Cholera Vaccine Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Cholera Vaccine Price by Application (2015-2020)
  • 6.6 China Cholera Vaccine Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Cholera Vaccine Sales Forecast by Application (2021-2026)
    • 6.6.2 China Cholera Vaccine Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Cholera Vaccine Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Cholera Vaccine Market Size YoY Growth 2015-2026
  • 7.2 North America Cholera Vaccine Market Facts & Figures by Country
    • 7.2.1 North America Cholera Vaccine Sales by Country (2015-2020)
    • 7.2.2 North America Cholera Vaccine Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Cholera Vaccine Market Size YoY Growth 2015-2026
  • 8.2 Europe Cholera Vaccine Market Facts & Figures by Country
    • 8.2.1 Europe Cholera Vaccine Sales by Country
    • 8.2.2 Europe Cholera Vaccine Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Cholera Vaccine Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Cholera Vaccine Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Cholera Vaccine Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Cholera Vaccine Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Cholera Vaccine Market Size YoY Growth 2015-2026
  • 10.2 Latin America Cholera Vaccine Market Facts & Figures by Country
    • 10.2.1 Latin America Cholera Vaccine Sales by Country
    • 10.2.2 Latin America Cholera Vaccine Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Cholera Vaccine Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Cholera Vaccine Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Cholera Vaccine Sales by Country
    • 11.2.2 Middle East and Africa Cholera Vaccine Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Valneva
    • 12.1.1 Valneva Corporation Information
    • 12.1.2 Valneva Description and Business Overview
    • 12.1.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Valneva Cholera Vaccine Products Offered
    • 12.1.5 Valneva Recent Development
  • 12.2 PaxVax
    • 12.2.1 PaxVax Corporation Information
    • 12.2.2 PaxVax Description and Business Overview
    • 12.2.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 PaxVax Cholera Vaccine Products Offered
    • 12.2.5 PaxVax Recent Development
  • 12.3 Shantha Biotechnics Limited
    • 12.3.1 Shantha Biotechnics Limited Corporation Information
    • 12.3.2 Shantha Biotechnics Limited Description and Business Overview
    • 12.3.3 Shantha Biotechnics Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Shantha Biotechnics Limited Cholera Vaccine Products Offered
    • 12.3.5 Shantha Biotechnics Limited Recent Development
  • 12.4 Celldex Therapeutics
    • 12.4.1 Celldex Therapeutics Corporation Information
    • 12.4.2 Celldex Therapeutics Description and Business Overview
    • 12.4.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Celldex Therapeutics Cholera Vaccine Products Offered
    • 12.4.5 Celldex Therapeutics Recent Development
  • 12.5 Merck
    • 12.5.1 Merck Corporation Information
    • 12.5.2 Merck Description and Business Overview
    • 12.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Merck Cholera Vaccine Products Offered
    • 12.5.5 Merck Recent Development
  • 12.6 Ceva Asia
    • 12.6.1 Ceva Asia Corporation Information
    • 12.6.2 Ceva Asia Description and Business Overview
    • 12.6.3 Ceva Asia Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Ceva Asia Cholera Vaccine Products Offered
    • 12.6.5 Ceva Asia Recent Development
  • 12.7 Sanofi
    • 12.7.1 Sanofi Corporation Information
    • 12.7.2 Sanofi Description and Business Overview
    • 12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Sanofi Cholera Vaccine Products Offered
    • 12.7.5 Sanofi Recent Development
  • 12.11 Valneva
    • 12.11.1 Valneva Corporation Information
    • 12.11.2 Valneva Description and Business Overview
    • 12.11.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Valneva Cholera Vaccine Products Offered
    • 12.11.5 Valneva Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Cholera Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cholera Vaccine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Cholera Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cholera Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Cholera Vaccine market is segmented into
    Dukoral
    Shanchol
    Vaxchora
    Others

    Segment by Application, the Cholera Vaccine market is segmented into
    Hospital
    Scientific Research
    Others

    Regional and Country-level Analysis
    The Cholera Vaccine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cholera Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Cholera Vaccine Market Share Analysis
    Cholera Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholera Vaccine business, the date to enter into the Cholera Vaccine market, Cholera Vaccine product introduction, recent developments, etc.
    The major vendors covered:
    Valneva
    PaxVax
    Shantha Biotechnics Limited
    Celldex Therapeutics
    Merck
    Ceva Asia
    Sanofi
    ...

    Buy now